AMENDMENT TO INVESTMENT AGREEMENTInvestment Agreement • April 18th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining • Nevada
This Amendment to the Investment Agreements (this “Amendment”) is made as of April 12, 2017 (the “Effective Date”), by and between Opiant Pharmaceuticals, Inc. (formerly known as Lightlake Therapeutics Inc.), a Nevada corporation (“Company”) and Potomac Construction Limited (the “Investor”). Capitalized terms used but not defined herein have the meanings given to them in the Investment Agreements (as defined below).
